Akiko Tomokuni

601 total citations
16 papers, 415 citations indexed

About

Akiko Tomokuni is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Akiko Tomokuni has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Akiko Tomokuni's work include Inflammatory Myopathies and Dermatomyositis (6 papers), Cell death mechanisms and regulation (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Akiko Tomokuni is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (6 papers), Cell death mechanisms and regulation (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Akiko Tomokuni collaborates with scholars based in Japan, Malta and Qatar. Akiko Tomokuni's co-authors include Takemi Otsuki, Masayasu Kusaka, A Ueki, Haruko Sakaguchi, Yumika Isozaki, Fuminori Hyodoh, Hiroaki Ueki, Takakazu Matsuki, Ayako Ueki and Hiroshi Ueki and has published in prestigious journals such as The Science of The Total Environment, British Journal of Haematology and Clinical & Experimental Immunology.

In The Last Decade

Akiko Tomokuni

16 papers receiving 400 citations

Peers

Countries citing papers authored by Akiko Tomokuni

Since Specialization

Citations

This map shows the geographic impact of Akiko Tomokuni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Tomokuni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Tomokuni more than expected).

Fields of papers citing papers by Akiko Tomokuni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Tomokuni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Tomokuni. The network helps show where Akiko Tomokuni may publish in the future.

Co-authorship network of co-authors of Akiko Tomokuni

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Tomokuni. A scholar is included among the top collaborators of Akiko Tomokuni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Tomokuni. Akiko Tomokuni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Detection of anti-topoisomerase I autoantibody in patients with silicosis 2002 ·Environmental Health and Preventive Medicine ·Akiko Tomokuni, Takemi Otsuki, Haruko Sakaguchi, Yumika Isozaki, Fuminori Hyodoh, Masayasu Kusaka, Ayako Ueki	14
2	Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals 2002 ·Clinical & Experimental Immunology ·A Ueki, Yumika Isozaki, Akiko Tomokuni, Tamayo Hatayama, Hiroaki Ueki, Masayasu Kusaka, (unknown), (unknown), Tatsuya Takeshita, (unknown)	36
3	Detection of Anti-Topoisomerase I Autoantibody in Patients with Silicosis 2002 ·Environmental Health and Preventive Medicine ·Akiko Tomokuni, Takemi Otsuki, Haruko Sakaguchi, Yumika Isozaki, Fuminori Hyodoh, Masayasu Kusaka, Ayako Ueki	3
4	Reduced Expression of the Survivin Gene in PBMC from Silicosis Patients 2001 ·(unknown), Takemi Otsuki, (unknown), (unknown), Haruko Sakaguchi, Akiko Tomokuni, Fuminori Hyodoh, Masayasu Kusaka, Ayako Ueki	3
5	Different Distribution of HLA Class II Alleles in Anti-Topoisomerase I Autoantibody Responders between Silicosis and Systemic Sclerosis Patients, with a Common Distinct Amino Acid Sequence in the HLA-DQB1 Domain 2001 ·Immunobiology ·Ayako Ueki, Yumika Isozaki, Akiko Tomokuni, Hiroaki Ueki, Masayasu Kusaka, Shinichiro Tanaka, Takemi Otsuki, Haruko Sakaguchi, Fuminori Hyodoh	22
6	Antidesmoglein Autoantibodies in Silicosis Patients with No Bullous Diseases 2001 ·Dermatology ·Hiroaki Ueki, (unknown), (unknown), (unknown), (unknown), (unknown), Takashi Hashimoto, Ayako Komai, Akiko Tomokuni, A Ueki	25
7	Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1 0402 allele in Japanese silicosis patients 2001 ·The Science of The Total Environment* ·A Ueki, Yumika Isozaki, Akiko Tomokuni, Shinichiro Tanaka, Takemi Otsuki, Takumi Kishimoto, Masayasu Kusaka, (unknown), Haruko Sakaguchi, (unknown)	11
8	Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients 2000 ·Immunology Letters ·Takemi Otsuki, Haruko Sakaguchi, Akiko Tomokuni, (unknown), Takakazu Matsuki, Yumika Isozaki, Fuminori Hyodoh, Yasuhiko Kawakami, Masayasu Kusaka, (unknown), Ayako Ueki	25
9	Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients 2000 ·Clinical & Experimental Immunology ·Takemi Otsuki, Akiko Tomokuni, Haruko Sakaguchi, (unknown), Takakazu Matsuki, Yumika Isozaki, Fuminori Hyodoh, Hiroaki Ueki, Masayasu Kusaka, (unknown), A Ueki	52
10	Reduced Expression of the Inhibitory Genes for Fas‐Mediated Apoptosis in Silicosis Patients 2000 ·Journal of Occupational Health ·Takemi Otsuki, Akiko Tomokuni, Haruko Sakaguchi, Fuminori Hyodoh, Masayasu Kusaka, Ayako Ueki	13
11	Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis. 1999 ·International Journal of Molecular Medicine ·Takemi Otsuki, Kiyoshi Ichihara, Akiko Tomokuni, Haruko Sakaguchi, (unknown), Takakazu Matsuki, Yumika Isozaki, Fuminori Hyodoh, Masayasu Kusaka, (unknown), A Ueki	13
12	Man-made mineral fibers induce apoptosis of human peripheral blood mononuclear cells similarly to chrysotile B. 1999 ·International Journal of Molecular Medicine ·Zhongliang Ma, Takemi Otsuki, Akiko Tomokuni, (unknown), Takakazu Matsuki, Haruko Sakaguchi, Yumika Isozaki, Fuminori Hyodoh, (unknown), (unknown), A Ueki	8
13	Human myeloma cell apoptosis induced by interferon‐α 1998 ·British Journal of Haematology ·Takemi Otsuki, Osamu Yamada, Haruko Sakaguchi, Akiko Tomokuni, Hideho Wada, Yoshihito Yawata, Ayako Ueki	45
14	Soluble Fas mRNA is dominantly expressed in cases with silicosis 1998 ·Immunology ·Takemi Otsuki, Haruko Sakaguchi, Akiko Tomokuni, (unknown), Takakazu Matsuki, Yasuhiko Kawakami, Masayasu Kusaka, Hiroaki Ueki, (unknown), A Ueki	45
15	Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro. 1998 ·International Journal of Oncology ·(unknown), Akiko Tomokuni, (unknown), Fuminori Hyodoh, Hiroshi Ueki, Takemi Otsuki, A Ueki	49
16	Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours 1997 ·Clinical & Experimental Immunology ·Akiko Tomokuni, (unknown), Takakazu Matsuki, Yumika Isozaki, Takemi Otsuki, (unknown), Hiroaki Ueki, Masayasu Kusaka, Takumi Kishimoto, A Ueki	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact